PARTICIPANT PROFILE · SEC DISCLOSURES
Wilson Sonsini Goodrich & Rosati, Professional Corporation.
Law Firm · 2 transactions · 2 issuers in the database
Transaction history
Roles below apply to each specific transaction. Participation is supported by the linked transaction sources.
| Compare | Date | Company | Deal | Gross proceeds | Role on this deal |
|---|---|---|---|---|---|
| Sep 11, 2026SEC disclosed | Nautilus Biotechnology, Inc.NAUT | ATM · Facility1 note | No cash proceeds | Issuer Counsel | |
| Aug 31, 2026 | PMV Pharmaceuticals, Inc.PMVP | Public Offering1 note | $50.8M | Issuer Counsel |
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.